Skip to main content
$171.93 $0.14 (0.1%)

12:59 PM EDT on 07/26/21

Johnson & Johnson (NYSE:JNJ)

CAPS Rating: 4 out of 5

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.

Current Price $171.93 Mkt Cap $452.4B
Open $171.82 P/E Ratio 25.47
Prev. Close $0.00 Div. (Yield) $4.24 (2.5%)
Daily Range $170.86 - $172.14 Volume 2,091,687
52-Wk Range $133.65 - $173.65 Avg. Daily Vol. 6,638,837

Caps

How do you think NYSE:JNJ will perform against the market?

Add Stock to CAPS Watchlist

All Players

13,616 Outperform
511 Underperform
 

All-Star Players

2,427 Outperform
54 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:JNJ Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Dividends500 (79.82)
Submitted January 01, 2021

Dividends500 tracks the healthiest dividends in the S&P 500.To qualify for the portfolio, the company must meet three simple requirements:- Member of the S&P 500- Payout ratio below 50%- Dividend growth year over year

acegdl007 (78.37)
Submitted January 20, 2011

J&J is not a company that has experienced significant growth (in terms of stock price) over the past few years. It has mainly sustained its self on it's brand name recognition that has been significantly tarnished in 2010 due to several recalls.… More

Recent Community Commentary

Read the most recent pitches from players about JNJ.

Recs

0
Member Avatar TMFAdriaCimino (28.41) Submitted: 1/14/2021 8:50:20 AM : Outperform Start Price: $159.46 NYSE:JNJ Score: -7.90

J&J has a strong revenue and profit track record -- and a vast product portfolio. So I expect it to win over the long term.

Recs

0
Member Avatar naseerkhan (21.10) Submitted: 1/14/2021 12:16:42 AM : Outperform Start Price: $159.46 NYSE:JNJ Score: -7.90

COVID-19 vaccine finally showing good results

Recs

0
Member Avatar kewpiepoo (< 20) Submitted: 1/7/2021 12:36:46 PM : Outperform Start Price: $159.27 NYSE:JNJ Score: -8.41

- tons of optionality
- COVID19 Vaccine looks promising
- have patented a lot of hard-to-manufacture drugs
- diverse healthcare segments including auto-surgical equipment
- slow and steady growth

Leaderboard

Find the members with the highest scoring picks in JNJ.

Score Leader

juliojulio

juliojulio (< 20) Score: +146.65

The Score Leader is the player with the highest score across all their picks in JNJ.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
juliojulio < 20 11/21/2008 8/14/2009 Underperform 1Y $39.14 +339.30% +485.95% +146.65 0 Comment
jokester2222 < 20 2/19/2009 Underperform 3W $38.68 +344.56% +470.31% +125.74 0 Comment
Nonnah 37.07 2/19/2009 Underperform 3W $38.99 +341.01% +461.94% +120.93 0 Comment
erkleiner < 20 11/24/2008 Underperform NS $40.75 +321.96% +439.19% +117.22 0 Comment
bullear1 57.07 7/24/2007 Outperform 3Y $40.96 +319.83% +202.81% +117.02 0 Comment
jbarnes1217 90.82 7/24/2007 Outperform 3Y $40.96 +319.83% +202.81% +117.02 0 Comment
paladin65 < 20 7/24/2007 Outperform 1Y $40.96 +319.83% +202.81% +117.02 1 Comment
cando123 < 20 7/24/2007 Outperform 5Y $40.96 +319.83% +202.81% +117.02 0 Comment
GreedyMo < 20 7/24/2007 9/30/2012 Outperform 5Y $40.96 +319.83% +202.81% +117.02 0 Comment
fartalope < 20 7/24/2007 Outperform 5Y $40.96 +319.83% +202.81% +117.02 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for JNJ.